Status:
RECRUITING
Association Between Gut Microbiome and Dietary Determinants and Vaccine Response
Lead Sponsor:
M.D. Anderson Cancer Center
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Influenza
Eligibility:
All Genders
18+ years
Brief Summary
This study evaluates the association between gut microbiome and dietary determinants and vaccine response. This study aims to learn if diet and the microbes (such as bacteria and viruses) found in you...
Detailed Description
PRIMARY OBJECTIVE: I. To evaluate the association of gut microbiome diversity with response to influenza vaccination as measured by vaccine-specific immune response. SECONDARY OBJECTIVE: I. To dete...
Eligibility Criteria
Inclusion
- MD Anderson employees and student employees with existing MRN
- Must be able to donate blood
- Participants must be age 18 or older
- Participants must receive the seasonal influenza vaccine at MD Anderson through Employee Health
- Participants must consent to gut microbiome profiling, REDCap-based dietary screening questionnaire (Appendix A) and survey (Appendix B), and vaccine immune response testing which requires one stool sample, and two blood draws
Exclusion
- 1\. Participants with a contraindication to the recommended annual influenza vaccine
- Pregnant women may be included in this study.
Key Trial Info
Start Date :
August 24 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 28 2027
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT05239403
Start Date
August 24 2021
End Date
February 28 2027
Last Update
August 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
M D Anderson Cancer Center
Houston, Texas, United States, 77030